184 related articles for article (PubMed ID: 27832954)
41. Sugars as solid dispersion carrier to improve solubility and dissolution of the BCS class II drug: clotrimazole.
Madgulkar A; Bandivadekar M; Shid T; Rao S
Drug Dev Ind Pharm; 2016 Jan; 42(1):28-38. PubMed ID: 25874729
[TBL] [Abstract][Full Text] [Related]
42. Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.
Ye X; Patil H; Feng X; Tiwari RV; Lu J; Gryczke A; Kolter K; Langley N; Majumdar S; Neupane D; Mishra SR; Repka MA
AAPS PharmSciTech; 2016 Feb; 17(1):78-88. PubMed ID: 26283197
[TBL] [Abstract][Full Text] [Related]
43. Different effects of silica added internal or external on in vitro dissolution of indomethacin hot-melt extrudates.
Xia Y; Yuan M; Deng Y; Ke X; Ci T
Int J Pharm; 2017 Dec; 534(1-2):272-278. PubMed ID: 29074389
[TBL] [Abstract][Full Text] [Related]
44. Physicochemical characterization of tacrolimus-loaded solid dispersion with sodium carboxylmethyl cellulose and sodium lauryl sulfate.
Park YJ; Ryu DS; Li DX; Quan QZ; Oh DH; Kim JO; Seo YG; Lee YI; Yong CS; Woo JS; Choi HG
Arch Pharm Res; 2009 Jun; 32(6):893-8. PubMed ID: 19557367
[TBL] [Abstract][Full Text] [Related]
45. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
Ahuja N; Katare OP; Singh B
Eur J Pharm Biopharm; 2007 Jan; 65(1):26-38. PubMed ID: 16962750
[TBL] [Abstract][Full Text] [Related]
46. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
47. Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin.
Tajiri T; Morita S; Sakamoto R; Mimura H; Ozaki Y; Reppas C; Kitamura S
Int J Pharm; 2015 Jul; 490(1-2):368-74. PubMed ID: 26022889
[TBL] [Abstract][Full Text] [Related]
48. Triboelectrification and dissolution property enhancements of solid dispersions.
Asare-Addo K; Šupuk E; Al-Hamidi H; Owusu-Ware S; Nokhodchi A; Conway BR
Int J Pharm; 2015 May; 485(1-2):306-16. PubMed ID: 25772415
[TBL] [Abstract][Full Text] [Related]
49. Ultrasound influence on the solubility of solid dispersions prepared for a poorly soluble drug.
Pereira SV; Colombo FB; de Freitas LA
Ultrason Sonochem; 2016 Mar; 29():461-9. PubMed ID: 26548840
[TBL] [Abstract][Full Text] [Related]
50. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
51. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
[TBL] [Abstract][Full Text] [Related]
52. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
Al-Hamidi H; Obeidat WM; Nokhodchi A
Pharm Dev Technol; 2015 Jan; 20(1):74-83. PubMed ID: 24392858
[TBL] [Abstract][Full Text] [Related]
53. Two-phase amorphous-amorphous solid drug dispersion with enhanced stability, solubility and bioavailability resulting from ultrasonic dispersion of an immiscible system.
Martínez LM; Videa M; López Silva T; Castro S; Caballero A; Lara-Díaz VJ; Castorena-Torres F
Eur J Pharm Biopharm; 2017 Oct; 119():243-252. PubMed ID: 28648863
[TBL] [Abstract][Full Text] [Related]
54. Application of spray-drying and electrospraying/electospinning for poorly water-soluble drugs: a particle engineering approach.
Bohr A; Boetker JP; Rades T; Rantanen J; Yang M
Curr Pharm Des; 2014; 20(3):325-48. PubMed ID: 23651398
[TBL] [Abstract][Full Text] [Related]
55. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
[TBL] [Abstract][Full Text] [Related]
56. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
Han YR; Lee PI
Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130
[TBL] [Abstract][Full Text] [Related]
57. Characterisation of protein stability in rod-insert vaginal rings.
Pattani A; Lowry D; Curran RM; McGrath S; Kett VL; Andrews GP; Malcolm RK
Int J Pharm; 2012 Jul; 430(1-2):89-97. PubMed ID: 22486955
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the Microcentrifuge Dissolution Method as a Tool for Spray-Dried Dispersion.
Wu B; Li J; Wang Y
AAPS J; 2016 Mar; 18(2):346-53. PubMed ID: 26831250
[TBL] [Abstract][Full Text] [Related]
59. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
60. Novel films for drug delivery via the buccal mucosa using model soluble and insoluble drugs.
Kianfar F; Chowdhry BZ; Antonijevic MD; Boateng JS
Drug Dev Ind Pharm; 2012 Oct; 38(10):1207-20. PubMed ID: 22204701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
